Library
PubMed Central Open Access
research article
Professional
Open access

bacteremia in a young patient with epidermolysis bullosa: A case report

Source: PubMed Central Open Access, NCBI / U.S. National Library of Medicine

Infectious Diseases & ImmunityLast synced 7/30/2026Status: syncedPMID: 42524701 pmidDOI: 10.1097/ID9.0000000000000205

Abstract species are rare, aerobic, gram-positive actinomycetes that are increasingly recognized as opportunistic pathogens affecting immunocompromised patients, such as those suffering from epidermolysis bullosa. Epidermolysis bullosa is a rare genetic disorder characterized by skin fragility that predisposes patients to chronic wounds and recurrent skin infections. The case of interest in this work was a 22-year-old male with a complex medical history, including the aforementioned disorder. He was admitted to the hospital’s emergency department, presenting with fluctuating low-grade fever and recurrent bleeding of the skin lesion on his flank. Infectious workup was sent, after which appropriate intravenous fluids were administered for resuscitation, along with broad-spectrum antibiotics. During the patient’s hospitalization, he was found to haveand methicillin-resistantbacteremia, which was treated with vancomycin administered intravenously. Treatment resulted in significant improvement. This case adds to the limited body of studies describingas a human pathogen. It highlights the importance of considering such rare opportunistic infectious agents in immunocompromised patients with chronic wounds and indwelling catheters. The study serves as a reference for clinicians, emphasizes the therapeutic challenges encountered in managing this infection in high-risk populations, and sheds the light on the need for established policies and clinical guidelines.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.